These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 27614756)

  • 1. Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.
    Marsico F; Cecere M; Parente A; Paolillo S; de Martino F; Dellegrottaglie S; Trimarco B; Perrone Filardi P
    J Thromb Thrombolysis; 2017 Feb; 43(2):139-148. PubMed ID: 27614756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment].
    Calabrò P; Gragnano F; Cesaro A; Pariggiano I; Patti G; Cavallari I; Parato VM; Renda G; De Caterina R;
    G Ital Cardiol (Rome); 2019 Jun; 20(6):374-383. PubMed ID: 31184324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.
    Ferner M; Wachtlin D; Konrad T; Deuster O; Meinertz T; von Bardeleben S; Münzel T; Seibert-Grafe M; Breithardt G; Rostock T
    Clin Res Cardiol; 2016 Jan; 105(1):29-36. PubMed ID: 26109251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A; Katz WE; Genuardi MV; Bhonsale A; Jain SK; Kancharla K; Saba S; Shalaby AA; Voigt AH; Wang NC
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1183-1190. PubMed ID: 31355470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy　- Warfarin vs. Direct Oral Anticoagulants.
    Kawabata M; Goya M; Sasaki T; Maeda S; Shirai Y; Nishimura T; Yoshitake T; Shiohira S; Isobe M; Hirao K
    Circ J; 2017 Apr; 81(5):645-651. PubMed ID: 28179613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous left atrial appendage closure after resolution of left atrial appendage thrombi with dabigatran].
    Kis Z; Földesi C; Pál M; Som Z; Csillik A; Abrahám P; Temesvári A; Fontos G; Szatmári A; Andréka P; Kardos A
    Orv Hetil; 2013 Feb; 154(7):262-5. PubMed ID: 23395790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    Bajaj NS; Kalra R; Patel N; Hashim T; Godara H; Ather S; Arora G; Pasala T; Whitfield TT; McGiffin DC; Ahmed MI; Lloyd SG; Limdi NA; Arora P
    PLoS One; 2016; 11(10):e0163608. PubMed ID: 27706224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.
    Ueberham L; Dagres N; Potpara TS; Bollmann A; Hindricks G
    Adv Ther; 2017 Oct; 34(10):2274-2294. PubMed ID: 28956288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J; Du X; Wu JH; Jia CQ; Li X; Ning M; Lyu J; Yang Y; Liu XH; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug; 46(8):606-610. PubMed ID: 30139010
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training].
    Casu G; Gulizia MM; Molon G; Mazzone P; Audo A; Casolo G; Di Lorenzo E; Portoghese M; Pristipino C; Ricci RP; Themistoclakis S; Padeletti L; Tondo C; Berti S; Oreglia JA; Gerosa G; Zanobini M; Ussia GP; Musumeci G; Romeo F; Di Bartolomeo R
    G Ital Cardiol (Rome); 2016; 17(7-8):594-613. PubMed ID: 27571335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future alternatives to warfarin for the prevention of stroke in atrial fibrillation.
    Bommer WJ
    Crit Pathw Cardiol; 2012 Jun; 11(2):45-54. PubMed ID: 22595814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation.
    Watanabe T; Shinoda Y; Ikeoka K; Minamisaka T; Fukuoka H; Inui H; Hoshida S
    Intern Med; 2017; 56(15):1977-1980. PubMed ID: 28768967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage and Closure: Who, When, and How.
    Holmes DR; Reddy VY
    Circ Cardiovasc Interv; 2016 May; 9(5):e002942. PubMed ID: 27139910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world.
    Bertaglia E; Anselmino M; Zorzi A; Russo V; Toso E; Peruzza F; Rapacciuolo A; Migliore F; Gaita F; Cucchini U; De Divitiis M; Iliceto S; Stabile G
    Int J Cardiol; 2017 Dec; 249():179-183. PubMed ID: 29121724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage closure for prevention of cardioembolic events.
    Gloekler S; Meier B; Windecker S
    Swiss Med Wkly; 2016; 146():w14298. PubMed ID: 27244534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants.
    Angelini F; Bocchino PP; Peyracchia M; Saglietto A; Magnano M; Patanè N; D'Ascenzo F; Giustetto C; Anselmino M; Gaita F; Toso E
    Acta Cardiol; 2023 May; 78(3):290-297. PubMed ID: 34821203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
    Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
    Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.